United States

Managing third-party risks across your life sciences business

Know your risk factors and how to address them

E BOOK  | 


Leveraging third parties is a key business growth strategy and is increasing in the life sciences sector as these partnerships help pharmaceutical, medical device and biotechnology companies complete important research and clinical trials as well as commercialize, manufacture and distribute products. Often, these relationships provide greater process efficiencies, operational effectiveness and cost savings by shifting noncore functions to more specialized third-party providers.

However, while there are many benefits to working with third parties, there are also risks. Failure to properly manage these third-party relationships can result in financial loss or expose an organization to unwelcome regulatory or legal challenges. Life sciences companies must understand the risk factors involved with these relationships, from initial planning to third-party termination, to proactively mitigate and manage them in a responsible manner.

This e-book explores many of the key risk factors related to third-party relationship management for life sciences organizations, including the following:

  • Security and privacy
  • Anti-bribery
  • Contract compliance
  • Fraud
  • Regulatory compliance
  • Mergers and acquisitions
  • Technology solutions
  • Process improvement

Each third-party relationship should be evaluated to consider these areas of focus. Throughout this e-book, you will learn the importance of these focus areas and tips to reduce your risks.

Download “Managing third-party risks across your life sciences business" today.


Life Sciences Insights

( * = Required fields)